As awareness around newborn stem cell preservation continues to grow, expectant parents now have access to more information than ever before. This has helped many families understand the value of preserving cord blood and cord tissue, but it has also led to the spread of common misconceptions that can make the decision feel more confusing than it needs to be.

Some parents may assume that stem cell preservation has limited relevance today. Others may believe that it is incompatible with delayed cord clamping or that public donor registries can always provide an equivalent alternative when needed. While these ideas are often repeated,  they do not always reflect how newborn stem cell preservation works or the factors families may need to consider.

Understanding the facts can help parents make a more informed decision during pregnancy. In this article, we’ll address some of the most common misconceptions about newborn stem cell preservation and explain what parents should know before making a choice.

Understanding Newborn Stem Cell Preservation and Its Components 

Newborn stem cell preservation refers to the collection and long-term storage of stem cells from a baby’s umbilical cord immediately after birth. These cells are naturally present in the cord blood and cord tissue at the time of delivery and can be collected through a safe and non-invasive process after the baby is born and the umbilical cord has been clamped and cut.

The purpose of this process is to preserve a biological resource that is available only at birth. Once the cord blood and cord tissue are collected, they are processed and stored under controlled cryogenic conditions for potential future medical use, depending on clinical need, suitability, and medical guidance at that time.

Newborn stem cell preservation typically involves two important sources:

Cord Blood

Cord blood is the blood that remains in the umbilical cord and placenta after birth. It is a rich source of haematopoietic stem cells, which are blood-forming stem cells. These cells are currently used in established stem cell transplantation procedures for certain blood disorders, immune system conditions, and metabolic diseases.

Cord Tissue

Cord tissue refers to a small segment of the umbilical cord itself. It contains mesenchymal stem cells, which are being studied in ongoing research for their potential role in regenerative medicine, tissue repair, and other emerging therapeutic areas.

Together, cord blood and cord tissue provide different types of stem cells with distinct biological properties. Preserving both may help families store a broader range of newborn stem cells for potential future use, subject to medical suitability and scientific evidence.

Now that the basic components of newborn stem cell preservation are clear, it is useful to look at some of the common misconceptions that often surround the topic.

Myth #1: Delayed Cord Clamping Means Stem Cell Collection is Not Possible

Delayed cord clamping involves waiting for a short period after birth before clamping and cutting the umbilical cord. Since cord blood is collected after delivery, some parents may assume that delaying cord clamping leaves no blood available for stem cell preservation. This can lead to the belief that they must choose between delayed cord clamping and preserving their baby's stem cells.

In practice, the relationship between the two is not always that straightforward. In many cases, cord blood collection may still be possible after standard delayed cord clamping, although the volume collected can vary depending on the duration of delay, placental blood flow, and individual delivery circumstances.

It is also important to understand that newborn stem cell preservation is not limited to cord blood alone. Cord tissue, which contains a different population of stem cells, is collected from a small segment of the umbilical cord after birth. Because of this, cord tissue preservation is usually less affected by delayed cord clamping than cord blood collection, though final collection always depends on clinical suitability at the time of delivery.

Myth #2: Stem Cell Preservation is Just a Future Possibility with No Real Medical Use Today

Some parents assume that newborn stem cell preservation is based entirely on treatments that may become available in the future. Because stem cell research often appears in news reports and scientific discussions, it can create the impression that preserving stem cells is mainly a long-term decision linked only to future medical advancements.

This perception overlooks an important fact: cord blood stem cells already have established clinical uses today.

For decades, cord blood stem cells have been used in haematopoietic stem cell transplantation  for certain blood disorders, immune deficiencies, metabolic conditions, and some cancers. These are recognised clinical applications supported by extensive medical experience and are not dependent only on future scientific developments.

At the same time, researchers continue to investigate additional uses for stem cells, particularly those derived from cord tissue. Many of these potential applications are still under study, especially in areas such as regenerative medicine and tissue repair. This means cord blood and cord tissue should be understood differently: cord blood has established transplant uses today, while cord tissue is primarily associated with ongoing research and emerging possibilities.

Myth #3: Public Donor Registries Can Always Provide a Suitable Match

Some parents assume that newborn stem cell preservation is unnecessary, because compatible stem cells can always be found through public cord blood banks or bone marrow donor registries if they are ever needed. While these programmes have helped many patients worldwide, a suitable donor match is not guaranteed in every case.

Stem cell transplantation often depends on compatibility between the donor and recipient, especially through human leukocyte antigen, or HLA, markers. Identifying a suitable match may involve searching available registries, evaluating donor compatibility, and considering factors such as cell dose, medical urgency, and the patient’s specific condition. This process can take time, and in some cases, a fully suitable match may not be available when needed.

This is where preserved newborn stem cells differ from donor-dependent options. When cord blood has been preserved, the stored sample is already collected, processed, and available for medical evaluation if a future clinical need arises. However, preservation does not automatically mean the sample will be used in every situation. Suitability depends on the diagnosis, the quality and quantity of the stored cells, HLA compatibility, and the treating doctor’s recommendation.

In addition, biological relatives may share varying degrees of compatibility, which may be considered depending on the clinical situation. For families, this makes newborn stem cell preservation a way to keep a potentially valuable biological resource available, while still recognising that treatment decisions must always be guided by medical need and specialist advice.

Myth #4: Healthy Families Do Not Need to Consider Stem Cell Preservation

A common misconception is that stem cell preservation is only relevant for families with a known history of serious medical conditions. As a result, some parents assume that if both parents and the baby are healthy, there is little reason to consider preserving cord blood or cord tissue.

However, stem cell preservation is not based solely on current health status or family medical history. Certain conditions for which stem cell transplantation may be considered can develop later in life and may not be predictable at birth. In many cases, there is no prior indication that such a condition could occur.

For this reason, the decision to preserve newborn stem cells is often viewed as a way of retaining future options rather than responding to an existing medical need. The value lies in preserving access to a unique biological resource that is available only once, while recognising that its future use depends on the medical condition, cell suitability, and specialist guidance.

It is also important to understand that preserved stem cells are not a guaranteed treatment for every disease. For some conditions, a patient’s own stored cells may not be suitable, and doctors may recommend donor cells or other treatment options instead.

Cord blood and cord tissue can only be collected at the time of birth. Once the umbilical cord and placenta are discarded after delivery, the opportunity to preserve these newborn stem cells cannot be revisited.

Myth #5: Stored Stem Cells Expire After a Few Years

A common assumption is that stored stem cells gradually lose their usefulness after a few years. This can create the impression that newborn stem cell preservation is reliable only for a short period and may not hold value in the long term.

In reality, stem cells are preserved through cryogenic storage at extremely low temperatures, commonly below -150°C and up to -196°C in liquid nitrogen-based storage systems. At these temperatures, biological activity is placed in a state of suspension, which helps prevent the normal aging and cellular changes seen in living tissue.

When collected, processed, and stored under validated conditions, cord blood stem cells can remain preserved for extended periods. Studies have shown that cryopreserved cord blood units can retain viability and functional potential even after decades of storage, although the suitability of any stored sample depends on laboratory quality parameters and medical evaluation at the time of potential use.

Therefore, stored stem cells should not be thought of as expiring after a few years. Their long-term value depends on proper collection, processing, cryogenic storage, continuous monitoring, and quality assessment rather than a simple time-based expiry period.

Final Thoughts 

Many of the common misconceptions around newborn stem cell preservation arise from incomplete or misunderstood information. Once these misconceptions are clarified, it becomes easier to understand that stem cell preservation is not about guaranteeing a future treatment, but about preserving access to a unique biological resource available only at birth.

For expectant parents, the decision may involve several practical and personal considerations, including medical relevance, family history, storage standards, long-term value, and newborn stem cell preservation costs. Discussing these factors with a qualified stem cell banking provider can help parents better understand the collection process, processing protocols, storage conditions, quality safeguards, and associated costs.

With the right information, families can make a more informed decision based on their needs, preferences, and medical guidance, rather than on misconceptions or assumptions.